Bicara Therapeutics Inc. BCAX
Set alert
9.13 USD -0.60 -6.17%
At close · Oct 30
8.98 -0.15 -1.65%
After hours · Oct 30, 7:42 PM ET
8.36 Day range 9.38
9.13 52-week range 30.40
- YTD
- -45.75%
- 1 year
- -44.53%
- Open
- 9.38
- Prev close
- 9.73
- Mkt cap
- 604.16M
- Vol
- 4.20M
- Avg vol
- 973.12K
- EPS
- -3.08
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 8.36
- High
- 9.38
- Forward P/E
- -4.96
- Beta
- -0.69
- Short ratio
- 16.85
- Inst. own
- 102.47%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 9, 2026
- 50-d avg
- 20.82
- 200-d avg
- 21.33
- 1y target
- 35.67
MAX chart
Events in this range
- Aug 12, 2025Earnings: -0.5; estimate -0.54; surprise 7.41%
- Nov 10, 2025Earnings: -0.67; estimate -0.55; surprise -21.82%
- Mar 26, 2026Earnings: -0.68; estimate -0.72; surprise 5.56%
- May 11, 2026Earnings: -0.93; estimate -0.64; surprise -45.31%
- Aug 11, 2026Earnings: -0.82; estimate -0.81978; surprise -0.03%
- Aug 12, 2026Rating: Mizuho · Neutral → Neutral
- Aug 12, 2026Rating: Morgan Stanley · Overweight → Overweight
- Aug 12, 2026Rating: Wedbush · Outperform → Outperform
- Aug 12, 2026Rating: Goldman Sachs · Neutral → Neutral
- Aug 19, 2026Rating: BMO Capital · — → Outperform
- Oct 19, 2026Rating: BTIG · Buy → Buy
Signals (38)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 26, 2026 | 6 days ago |
| SMA: Bearish | Sep 14, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 17, 2026 | 2 months ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| RSI: Overbought | Jun 29, 2026 | 4 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 15, 2026 | 4 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| MACD: Sell Signal | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| RSI: Overbought | Apr 13, 2026 | 6 months ago |
| MACD: Buy Signal | Mar 9, 2026 | 7 months ago |
| SMA: Bullish | Feb 23, 2026 | 8 months ago |
| SMA: Bullish | Feb 16, 2026 | 8 months ago |
| SMA: Bearish | Feb 9, 2026 | 8 months ago |
| MACD: Sell Signal | Jan 19, 2026 | 9 months ago |
| SMA: Bearish | Jan 12, 2026 | 9 months ago |
| SMA: Bullish | Jan 5, 2026 | 10 months ago |
| SMA: Bearish | Dec 22, 2025 | 10 months ago |
| SMA: Bullish | Nov 17, 2025 | 11 months ago |
| SMA: Bearish | Nov 3, 2025 | 12 months ago |
| SMA: Bullish | Sep 22, 2025 | 1 year ago |
| SMA: Bullish | Sep 22, 2025 | 1 year ago |
| SMA: Bearish | Sep 15, 2025 | 1 year ago |
| SMA: Bearish | Sep 8, 2025 | 1 year ago |
| SMA: Bullish | Aug 18, 2025 | 1 year ago |
| SMA: Bullish | Aug 11, 2025 | 1 year ago |
| SMA: Bearish | Aug 4, 2025 | 1 year ago |
| SMA: Bullish | Jul 14, 2025 | 1 year ago |
| SMA: Bearish | May 19, 2025 | 1 year ago |
| SMA: Bullish | May 12, 2025 | 1 year ago |
| SMA: Bearish | May 5, 2025 | 1 year ago |
| SMA: Bullish | Apr 21, 2025 | 1 year ago |
| SMA: Bearish | Mar 31, 2025 | 1 year ago |
| SMA: Bullish | Mar 17, 2025 | 1 year ago |
| SMA: Bearish | Mar 10, 2025 | 1 year ago |
| SMA: Bullish | Mar 3, 2025 | 1 year ago |
Ownership
Held by insiders 10.07%
Held by institutions 102.47%
Float held by institutions 113.94%
Institutions 241
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| RA Capital Management, L.P. | 10.97% | 7,255,993 | 126.83M | Jun 29, 2026 |
| T. Rowe Price Investment Management, Inc. | 9.58% | 6,338,487 | 110.80M | Jun 29, 2026 |
| Siren, L.L.C. | 8.47% | 5,602,970 | 97.94M | Jun 29, 2026 |
| Vestal Point Capital, LP | 7.93% | 5,250,000 | 91.77M | Jun 29, 2026 |
| Deep Track Capital, Lp | 6.20% | 4,100,000 | 71.67M | Jun 29, 2026 |
| Blackrock Inc. | 5.82% | 3,848,090 | 67.26M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| T. Rowe Price Small-Cap Stock Fund, Inc. | 3.29% | 2,179,330 | 38.09M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.53% | 1,676,653 | 29.31M | Jun 29, 2026 |
| T. Rowe Price Eqy. Fd.s, Inc.-T. Rowe Price Inst. Small-Cap Stock Fd. | 1.77% | 1,170,492 | 20.46M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 1.73% | 1,144,022 | 20.00M | Sep 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.65% | 1,092,258 | 19.09M | Sep 29, 2026 |
| TR PRICE-Price (T.Rowe) U.S. Small-Cap Core Equity Trust | 1.52% | 1,004,231 | 17.55M | Jun 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| COHLHEPP RYAN | Chief Executive Officer | Conversion of Exercise of derivative security | Sep 7, 2026 | 181,641 |
| HYEP IVAN | Chief Financial Officer | Conversion of Exercise of derivative security | Aug 9, 2026 | 129,855 |
| MAZUMDAR CLAIRE | Chief Executive Officer | Conversion of Exercise of derivative security | Aug 9, 2026 | 362,152 |
| MEISNER LARA S. | Officer | Conversion of Exercise of derivative security | Sep 28, 2025 | 0 |
| RA CAPITAL MANAGEMENT, L.P. | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Feb 25, 2026 | 0 |
| RABEN DAVID M.D. | Officer | Conversion of Exercise of derivative security | Apr 26, 2026 | 55,286 |
Held by funds
93 US ETFs and mutual funds hold BCAX · largest positions